Salahuddin T, Richardson V, McNeal DM, Henderson K, et al. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab 2021;23:97-105.
PMID: 32902128